Welcome to our dedicated page for SelectQuote news (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on SelectQuote stock.
SelectQuote, Inc. operates a direct-to-consumer insurance distribution and healthcare services platform that connects consumers with Medicare, life, and auto and home insurance policies from carrier partners. Its model combines licensed agents, consultative needs analysis, proprietary lead sourcing and routing technology, and commission revenue from policy sales.
Recurring company developments include fiscal earnings, segment results for Senior, Healthcare Services, Life, and Auto & Home, Medicare Advantage policy volume, SelectRx membership and pharmacy economics, prescription drug reimbursement changes, and cash flow and capital-structure updates. SelectQuote also reports initiatives such as the SelectQuote Local franchise channel, research on e-broker access to Medicare Advantage, conference participation, and NYSE listing-standard compliance.
SelectQuote, Inc. (NYSE: SLQT) is set to release its fiscal third quarter 2023 financial results on May 11, 2023, before market opening. CEO Tim Danker and CFO Ryan Clement will conduct a conference call at 8:30 am ET to discuss these results. The call will be accessible via registration, with an invitation sent to participants via email.
Founded in 1985, SelectQuote specializes in providing Medicare insurance policies and operates a Healthcare Services platform. The company's services span several domains, including Medicare, Pharmacy, and Value-Based Care, aiming to enhance health outcomes and reduce healthcare costs. It has established four primary business lines: Senior, Healthcare Services, Life, and Auto and Home.
SelectQuote, Inc. (NYSE: SLQT) has regained compliance with the New York Stock Exchange’s minimum stock price requirement as of February 28, 2023. The company received a notice on March 1, 2023, confirming that its average share price exceeded $1.00, addressing a previous deficiency communicated on October 20, 2022. While there are no immediate plans for a reverse stock split, the company will seek shareholder approval for a proposal that allows the Board to effect a reverse split in the future if deemed necessary. A special meeting for stockholders is scheduled for March 2, 2023.
SelectQuote, Inc. (NYSE: SLQT), a distributor of Medicare insurance policies, announced that CEO Tim Danker, President Bob Grant, and CFO Ryan Clement will participate in Citi’s 2023 Healthcare Conference on March 2, 2023, at 1:15 PM ET in New York City. Management will engage in a fireside chat and will be accessible for one-on-one and small group investor meetings. This event will be webcast live; details can be found on SelectQuote's Investor Relations website. Founded in 1985, SelectQuote offers insurance solutions through its highly-trained agents and proprietary technology, focusing on Medicare, Pharmacy, and Value-Based Care services.
SelectQuote (NYSE: SLQT) has appointed Ryan Clement as Chief Financial Officer, effective immediately. Clement, who served as Interim CFO since May 2022, was previously the SVP of Financial Planning & Analysis. CEO Tim Danker praised Clement’s financial expertise and leadership, noting his critical role in enhancing the company's financial stability. Clement expressed confidence in the company’s strategy, emphasizing a focus on profitability and cash flow. SelectQuote operates across several business lines, including insurance and healthcare services, supporting millions of Americans in managing their health and property.
SelectQuote reported a strong second quarter for fiscal 2023 with consolidated revenue of $319.2 million, up from $194.2 million the previous year. The company posted a net income of $22.5 million, compared to a net loss of $137.6 million in Q2 2022. Adjusted EBITDA reached $63.6 million, a significant recovery from $(164.0 million) in the prior year. The Senior segment contributed $223.8 million in revenue, while Healthcare Services had $55.5 million despite a negative EBITDA of $(9.3 million). SelectQuote has updated its fiscal year guidance, expecting revenue between $910 million and $960 million with a net loss range of $94 million to $78 million.
SelectQuote (NYSE: SLQT) will release its fiscal Q2 2023 financial results on February 7, 2023, prior to market open. CEO Tim Danker and interim CFO Ryan Clement will host a conference call at 8:30 am ET on the same day to discuss these results. The company specializes in unbiased insurance price comparisons, helping consumers secure suitable policies. SelectQuote serves diverse markets including Medicare and Value-Based Care through its four core business lines. This upcoming report is expected to provide insights into financial performance and future outlook.
SelectQuote, Inc. (NYSE: SLQT) announced preliminary financial results for Q2 FY2023, estimating revenue between $300 million to $320 million and net income of $11 million to $23 million. Full-year guidance now expects revenue of $890 million to $960 million, with a reduced net loss forecast of $98 million to $78 million. CEO Tim Danker attributed the positive results to improved performance in Medicare distribution and strategic enhancements in agent hiring and marketing efficiency.
SelectQuote, Inc. (NYSE: SLQT) plans a special meeting on March 2, 2023, to seek stockholder approval for a reverse stock split of its common stock with a par value of $0.01. Stockholders of record as of January 11, 2023, will be eligible to vote. The reverse stock split is designed to not affect stockholders' ownership percentages, though fractional shares may be converted to cash. Details regarding the split ratio will be communicated later. The Board has the discretion to delay or abandon the proposal if deemed unbeneficial.
SelectQuote, Inc. (SLQT) reported consolidated revenue of $162.5 million for Q1 FY 2023, up from $156.1 million in Q1 FY 2022. The company experienced a net loss of $42.5 million, improved from a loss of $48.2 million a year prior. Adjusted EBITDA was $(27.5) million, compared to $(47.9) million. Segment highlights included Senior Revenue of $77.5 million and Healthcare Services Revenue of $43.1 million. SelectQuote reaffirmed its FY 2023 guidance, expecting revenue between $850 million and $950 million.
SelectQuote, Inc. (NYSE: SLQT) has received a notice from the NYSE for failing to meet compliance with the stock price requirement, as its average closing price was below $1.00 over 30 consecutive trading days. The company plans to notify the NYSE of its intent to remedy this deficiency within a six-month cure period. During this time, SLQT's stock will continue trading on the NYSE, provided it meets other continued listing standards. The company aims to meet the $1.00 stock price requirement to regain compliance.